Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2/3 3Phase 2 2Phase 4 1Phase 1/2 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 1Genitourinary 1

Conditions

Pain 3Neoplasms 2Tuberculosis 1Stomatitis 1Sarcoidosis 1Prostatic Neoplasms 1Pain, Postoperative 1Mucositis 1Lung Neoplasms 1Lung Diseases, Interstitial 1Liver Neoplasms 1Cough 1Cancer Pain 1Agnosia 1

Interventions

Lidocaine 3aluminum hydroxide, magnesium hydroxide, drug combination 1Water 1Transdermal Patch 1Radiosurgery 1Methadone 1Melatonin 1Glucose 1Fentanyl 1Diphenhydramine 1Diazepam 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Pain × Lidocaine × Clear all
NCT01384877 2019-07-12

Subcutaneous Lidocaine For Cancer-Related Pain

British Columbia Cancer Agency

Phase 2/3 Completed
33 enrolled 16 charts

Cancer Pain, Neoplasms, Pain

NCT02935972 2017-01-23

Combined Intravenous Diazepam, Local Periprostatic Nerve Block for Prostate Biopsy

Assiut University

Phase 2/3 Completed
336 enrolled
Genitourinary

Agnosia, Pain, Prostatic Neoplasms

NCT01837446 2013-04-23

Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer

Isfahan University of Medical Sciences

Phase 2/3 Completed
30 enrolled
Other

Pain, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡